Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test
Go back to Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.33 -0.3 (6.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $45.34 | |||
| Open | $4.63 | 52 Week Low | $15.92 | |||
| Day High | $4.67 | P/E | 1.86 | |||
| Day Low | $4.22 | EPS | $2.33 | |||
| Volume | 1,191,939 | |||||
| (NASDAQ: SOPH) | Delayed: 4.88 -0.32 (6.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.20 | 52 Week High | $ | |||
| Open | $5.20 | 52 Week Low | $ | |||
| Day High | $5.20 | P/E | N/A | |||
| Day Low | $4.81 | EPS | $ | |||
| Volume | 94,962 | |||||
